AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Wiit

Remuneration Information Apr 8, 2025

4197_def-14a_2025-04-08_7318352f-a6d1-424d-a193-9e7e3cef55fc.pdf

Remuneration Information

Open in Viewer

Opens in native device viewer

WIIT SpA Share capital €2,802,066 fully paid-in Tel: +39 02 36607500 Registered Office and Headquarters Tax Code/VAT Number: 01615150214 Fax: +39 03 36607505

DEFINITIONS

"Executive Directors" WIT's Executive Directors in office at the time.
"Shareholders' Meeting" WIT's Ordinary or Extraordinary Shareholders' Meeting.
"Shares" WII I 's no-par value common stock listed on the Euronext
Market (EXM).
"Civil Code" Royal Decree No. 262 of March 16, 1942, as amended and
supplemented.
"Corporate
Code"
Governance The Italian Stock Exchange (Borsa Italiana S.p.A.)
Corporate Governance Committee's Corporate
Governance Code for listed companies, in effect at the
Report Date, and made available at www.borsaitaliana.it
"Board
of
Auditors"
Statutory The Board of Statutory Auditors of WIT in office at the
time.
"Appointments
Remuneration Committee"
and The "Appointments and Remuneration Committee" of
WIIT in office at the time.
"Board of Directors" The Board of Directors of WIIT in office at the time.
"Chief Executive Officer" The Chief Executive Officer of WIJT in office at the time.
"Consob" Commissione Nazionale per le Società e la Borsa (Italian
market oversight authority).
"Report Date" March 11, 2025.
"Senior Executives" The parties defined as such in the Annex to the Consob
Related Party Transactions (RPT) Regulation.
EBIT" "Adjusted Consolidated The adjusted consolidated EBIT value of the Group as per
the consolidated financial statements approved by the
Board of Directors of the Company for the reference year.
The Adjusted Consolidated EBIT does not account for any
costs relating to the variable remuneration of Executive
Directors accrued or paid in the reporting year.
"Adjusted Target EBIT" The adjusted consolidated EBIT value of the Group to be
achieved in each reference year, defined by the Board of
Directors as part of the year's annual budget, to which the
set aside costs relating to the variable remuneration of
the Executive Directors is added. In the event of Group
transactions involving the acquisition or sale of equity
investments, companies, or business units, WII I's Board
of Directors may modify the reference year's Adjusted

Target EBIT to account for them.

  • "Adjusted Consolidated The Group's adjusted consolidated EBITDA as per the EBITDA" consolidated financial statements approved by the Company's Board of Directors for the reference year. The Adjusted Consolidated EBITDA does not account for any costs relating to the variable remuneration of Executive Directors accrued or paid in the reference year.
  • "Adjusted Target EBITDA" The adjusted consolidated EBITDA value of the Group to be achieved in each reference year, defined by the Board of Directors as part of the year's annual budget, to which the set aside costs relating to the variable remuneration of the Executive Directors is added. In the event of Group transactions involving the acquisition or sale of equity investments, companies, or business units, WIIT's Board of Directors may modify the reference year's Adjusted Target EBITDA to account for them.
  • "EXM" Euronext Milan, a market regulated by Borsa Italiana S.p.A.
  • "The Group" or "WIT and its subsidiaries pursuant to Article 93 of the CFA. Group"
  • "MBO" Has the meaning given to it in Section I, Paragraph 1.8.1, Sub-Paragraph "MBO", of this Report.
  • "2024-2026 LTI Plan" Has the meaning given to it in Section I, Paragraph 1.8.1, Sub-Paragraph "2024-2026 LTI Plan", of this Report.
  • "2021-2026 Stock Option Has the meaning given to it in Section I, Paragraph 1.8.1, Plan" Sub-Paragraph "2021-2026 Stock Option Plan", of this Report.
  • "2022-2027 Stock Option Has the meaning given to it in Section I, Paragraph 1.8.1, Plan" Sub-Paragraph "2022-2027 Stock Option Plan", of this Report.
  • "Welfare Plan" The corporate Welfare Plan for Executive Directors, Executives, and 1st and 2nd level employees approved by the Board of Directors on November 13, 2023.
  • "Remuneration Policy" The Company's Remuneration Policy, as described in this Remuneration Report.
  • "Related Parties Policy" WIIT S.p.A.'s Related Party Transactions Policy.
  • "Consob Related Party Consob Regulation No. 17221 of March 12, 2010 regarding Transactions Regulation" related party transactions, as subsequently amended and supplemented.

  • "Issuers' Regulation" The enacting regulation of the CFA concerning the governance of issuers, adopted by Consob with Resolution No. 11971 of May 14, 1999, as subsequently amended and supplemented.
  • "Remuneration Report" or This "Remuneration Policy and Report", prepared as per "Report" Article 123-ter of the Consolidated Finance Act (CFA) and Article 84-quater and Annex 3A, Schedule 7-bis, of the Issuers' Regulation, made available on the Company's website (https://www.wiit.cloud/it/), in the "Company -Corporate Governance Shareholders' Meeting" section, and via the "eMarket STORAGE" authorized storage mechanism ().
  • "2024 Remuneration The "Remuneration Policy and Report" prepared pursuant Report" to Article 123-terof the CFA and in accordance with Article 84-quater and Schedule 3A, Schedule 7-bis, of the Issuers' Regulation, approved by the Board of Directors on March 12, 2024. The 2024 Remuneration Report is available on the Company's website (https://www.wiit.cloud/it/), in the "Company - Corporate Governance - Shareholders' Meeting" section, and at the authorized storage mechanism "eMarket STORAGE" ().
  • "CFA" Legislative Decree No. 58 of February 24, 1998 (as subsequently amended and supplemented).
  • "WIIT" or the "Issuer" or the WIIT S.p.A., with registered office in Via dei Mercanti 12, "Company" Milan, and Tax Code, VAT and Milan, Monza Brianza and Lodi Companies Register No. 01615150214.

INTRODUCTION

This Remuneration Report is prepared pursuant to Article 123-ter of the CFA and Article 84quater of the Issuers' Regulation.

The Report was approved by the Board of Directors on March 11, 2025, upon the proposal of the Appointments and Remuneration Committee. It is divided into two Sections, drafted in accordance with Annex 3A, Schedule 7-bis, of the Issuers' Regulation.

Section I of the Report provides information on WIIT's policy for the remuneration of members of the Administration Boards, Senior Executives and members of the control bodies, in addition to the procedures used to adopt and apply this policy. Taking into account the organizational structure of the Company, the Issuer has identified three Senior Executives as at the Report Date (of whom one is a Non-Executive Director).

Section II of the Report sets out the individual items that make up the remuneration of the Company's Directors, Senior Executives and Statutory Auditors, and provides an analytical summary of the remuneration paid to these individuals in 2024 for any reason and in any form by the Company and any subsidiaries or affiliates.

SECTION I

1.1 review of the Remuneration Policy

The preparation, approval and implementation of the Remuneration Policy involves the following bodies and individuals, each to the extent within its remit:

  • the Board of Directors;
  • the Appointments and Remuneration Committee;
  • the Shareholders' Meeting;
  • the Board of Statutory Auditors; and
  • the independent audit firm.

The Board of Directors, upon the proposal of the Appointments and Remuneration Committee, defines and adopts the Remuneration Policy. After examining and approving the Remuneration Policy, the Board of Directors submits this to the binding vote of the Shareholders' Meeting, making it available at least 21 days before the date of the Shareholders' Meeting through the publication of the Remuneration Policy and Report.

The Remuneration Policy was reviewed by the Appointments and Remuneration Committee on March 5, 2025, and subsequently approved by the Board of Directors on March 11, 2025.

This Section I - prepared as per Article 123-ter, Paragraph 3, of the CFA - will be submitted for approval by the Shareholders' Meeting scheduled for April 29, 2025, as per Article 123-ter, Paragraph 3-bis, of the CFA.

Should the Shareholders' Meeting not approve the Remuneration Policy submitted for a vote pursuant to Article 123, paragraph 3-bis of the CFA, WIIT will continue to pay remuneration in accordance with the remuneration policy most recently approved by the Shareholders' Meeting. In this event, WIT shall submit a new Remuneration Policy to a vote of the shareholders, at the latest at the next Shareholders' Meeting provided for in Article 2364, paragraph 2, of the Civil Code.

****

Board of Directors

As noted above, the definition of WIIT's Remuneration Policy is entrusted to the Board of Directors, which makes use of the advisory and proposal-making activities of the Appointments and Remuneration Committee.

The Board of Directors resolves on the following matters:

  • distribution of the remuneration for Directors set by the Shareholders' Meeting (where the Meeting has not already done so);
  • definition of incentive plans to be submitted to the Shareholders' Meeting pursuant to Article 114-bis of the CFA;

  • application and execution of the incentive plans approved by the Shareholders' Meeting;
  • approval, application and execution of incentive plans for which no Shareholders' Meeting resolution is required under Article 114-bis CFA;
  • establishment of the Appointments and Remuneration Committee;
  • presentation to the Shareholders' Meeting of the Remuneration Policy pursuant to Article 123-ter CFA.

Appointments and Remuneration Committee

For information on the Appointments and Remuneration Committee, please refer to paragraph 2 of Section I of this Report.

Shareholders' Meeting

The Shareholders' Meeting:

  • establishes the total remuneration of the members of the Board of Directors in accordance with Article 2364, paragraph 1, No. 3) of the Civil Code;
  • may determine an overall amount for the remuneration of all Directors, including Executive Directors;
  • resolves, with a binding vote, as regards Section I of the Report, in accordance with Article 123-ter, paragraph 3-ter of the CFA;
  • resolves, with a non-binding vote, as regards Section II of the Report, in accordance with Article 123-ter, paragraph 6 of the CFA;
  • establishes any share-based remuneration plans or other financial instruments for Directors, employees or collaborators, including Senior Executives, in accordance with Article 114-bis of the CFA.

Board of Statutory Auditors

Pursuant to Article 2389, paragraph 3 of the Civil Code, the Board of Statutory Auditors expresses its opinion on proposals for the remuneration of Senior Directors, where not already established by the Shareholders' Meeting.

Independent Audit Firm

The independent audit firm verifies the Directors' preparation of Section II of the Report, as required by Article 123-ter, paragraph 8-bis of the CFA.

1.2 Committee

At the Report Date, as appointed by the Board of Directors on May 16, 2024, the Appointments and Remuneration Committee is composed of the following members:

  • Emanuela Basso Petrino (Chairperson);

  • Enrico Giacomelli; and ו
  • Annamaria Di Ruscio

On March 11, 2025, and on the basis of the information provided by the interested parties and that available to the Company, the Board of Directors assessed and declared the meeting of the independence requirements as per Article 148, paragraph 3 of the CFA, as referred to an Article 147-ter, paragraph 4 of the CFA, in addition to the Corporate Governance Code, of the aforementioned Directors.

The Board of Directors assessed that Enrico Giacomelli, as member of the Appointments and Remuneration Committee, possessed adequate knowledge and expertise in financial matters, considering his over twenty years of experience in managerial roles.

In support of the Board of Directors, the Appointments and Remuneration Committee is entrusted with the following tasks:

  • assists the Board of Directors in developing the Remuneration Policy;
  • periodically evaluates the adequacy, the overall consistency and the application of the remuneration policy for Directors and Senior Executives, utilizing for this latter information provided by the Chief Executive Officers;
  • presents proposals or express opinions to the Board of Directors on the remuneration of Executive Directors and other Senior Directors, and establishes the performance targets related to the variable component of this remuneration and monitors the application of the decisions adopted by the Board of Directors, verifying, in particular, the achievement of the performance targets.
  • assisting the Board of Directors in defining the size and composition of the Board and its internal committees;
  • monitoring the adequacy and the transparency of the self-assessment process of the Board of Directors;
  • ensuring the transparency of the slate of Directors presented by the outgoing Board of Directors;
  • proposing to the Board of Directors candidates for the office of Director in the cases of co-option; and
  • undertaking the preparatory works for the drawing up of a succession plan for Executive Directors and the Chief Executive Officer, where the Board of Directors has decided to adopt such a plan.

1.3 Independent experts

The Remuneration Report was prepared without the involvement of independent experts.

1.4 The relationship between the Remuneration Policy and the working conditions of Group employees

In applying to certain figures and their roles, while the Remuneration Policy does not explicitly

consider the non-comparable remuneration and working conditions of the Company's general employees, it uses the same tools and logic as applied to the entire company population, targeted at attracting, motivating and retaining people with the professional qualities to contribute to the growth and promotion of the long-term interests and sustainability of the Company and the Group.

In particular, the remuneration of almost all the Company's employees includes an annual variable component payable on the basis of the achievement of specific performance targets, as identified by the heads of the various corporate departments. We also note that, with reference to the medium- to long-term variable component for employees of WIIT and other Group companies, that:

  • on May 5, 2021, the Shareholders' Meeting approved, as per Article 114-bis of the CFA, the 2021-2025 RSU Plan for employees (potentially including Senior Executives) of WIT and other Group companies, as defined by WIT's Board of Directors. This plan provides for the granting of Restricted Stock Units (RSUs) for the allocation of shares, upon achievement of certain Group targets for the financial years 2021, 2022, 2023, and 2024. Shares deriving from the conversion of RSUs will be allocated in the current financial year. For more information, please see the prospectus prepared in accordance with Article 84-bis of the Issuers' Regulation and Annex 3A of the Issuers' Regulation available to the public at the registered office, on the authorized storage mechanism "eMarket STORAGE" () and on the Company's website (http://www.wiit.cloud/), in the "Company - Corporate Governance - Shareholders' Meeting" section;
  • on May 4, 2023, the Shareholders' Meeting approved, as per Article 114-bis of the CFA, an incentive plan called the "2023-2027 RSU Plan" for employees (excluding Senior Executives) of WIT and other Group companies, as identified by WIT's Board of Directors. This plan provides for the granting of Restricted Stock Units (RSUs, as defined below) for the allocation of shares, upon achievement of certain Group targets for the financial years 2023, 2024, 2025, and 2026. For more information, please see the prospectus prepared in accordance with Article 84-bis of the Issuers' Regulation and Annex 3A of the Issuers' Regulation available to the public at the registered office, on the authorized storage mechanism "eMarket STORAGE" () and on the Company's website (http://www.wiit.cloud/), in the "Company - Corporate Governance -Shareholders' Meeting" section;
  • pursuant to Article 114-bis of the CFA, the Shareholders' Meeting called for April 29, 2025 will be asked to approve an incentive plan called the "2025-2029 RSU Plan" for employees (excluding Senior Executives) of WIT and other Group companies, as identified by WIT's Board of Directors. This plan provides for the granting of Restricted Stock Units (RSUs, as defined below) for the allocation of shares, upon achievement of certain Group targets for the financial years 2025, 2026, 2027, 2028, and 2029. For more information, please see the prospectus prepared in accordance with Article 84-bis of the Issuers' Regulation and Annex 3A of the Issuers' Regulation available to the public at the registered office, on the authorized storage mechanism "eMarket STORAGE" () and on the Company's website (http://www.wiit.cloud/), in the "Company - Corporate Governance - Shareholders' Meeting" section.

Finally, regarding non-monetary benefits, on November 13, 2023, the Board of Directors approved the Welfare Plan, applying to not only Executive Directors and Senior Executives, but also all other managerial figures, in addition to 18 and 200 level employees. In this regard, we note that the Welfare Plan provides the same non-monetary benefits to all recipients, differentiated only in terms of the amounts applied to respective categories.

Purpose, principles and duration of the Remuneration Policy, and changes 1.5 from the previous year's Remuneration Policy. Shareholders' Meeting vote and considerations

In accordance with the law, the Remuneration Policy has a maximum duration of three financial years, without prejudice to the Board of Directors' right to submit to the Shareholders' Meeting a new Remuneration Policy and/or any changes it deems appropriate during that period.

The WIIT Group's key personnel remuneration system is targeted at attracting, motivating and retaining key resources, at aligning the interests of key personnel with those of shareholders, and at creating a strong link between remuneration and WIIT Group performance.

Through the Remuneration Policy, WIIT pursues the following objectives:

  • link the remuneration of the WIT Group's key resources to the actual economic performance of the Company, and to the creation of value for WIIT Group;
  • orient the WIIT Group's key staff to medium-to long-term strategic objectives;
  • align the interests of the WIT Group's key resources with those of its shareholders.
  • introduce retention policies designed to retain key resources within WIIT Group.

In order to achieve these objectives in line with general principles, it is envisaged that:

  • the fixed and variable components are adequately balanced with strategic objectives and risks, considering the business sector in which the WIIT Group operates;
  • a significant portion of the remuneration of Executive Directors is related to the financial results achieved by the Company and by the WIT Group and/or meeting specific targets indicated by the Board of Directors beforehand.
  • the remuneration is sufficient to attract, retain and motivate people with the professional qualities to successfully manage the Company, and align their interests with the primary goal of creating value for shareholders over the medium to long term.

As regards the changes from the Remuneration Policy contained in the 2024 Remuneration Report, we note:

a change to the MBO (as defined below) for Senior Executives. Specifically, (i) the Component linked to Group targets was supplemented by providing for EBIT in addition to EBITDA, and (ii) a stand-alone ESG Component was introduced (previously provided for in the Remuneration Policy contained in the 2024 Remuneration Report in the Function Targets Component). This results in a change in the weighting of the individual

Components in relation to the overall MBO value;

  • the inclusion of information on the Board of Directors' allocation of the total gross . annual remuneration awarded by the Shareholders' Meeting of May 16, 2024;
  • supplementation of the disclosure regarding monetary variable remuneration provided in the event of termination of office or termination of employment.

Finally, the Remuneration Policy contained in the 2024 Remuneration Report was approved by the Shareholders' Meeting on May 16, 2024. Votes in favor totaled 70.150795% of the total voting rights and 89.347716% of the total voting rights present. No questions and/or comments in relation to the Remuneration Policy were received from parties entitled to attend before or during the Shareholders' Meeting pursuant to Article 127-ter of the CFA.

1.6 Description of the policies regarding fixed and variable components

Executive Directors

In line with the provisions of Section I, paragraph 1.5 of this Report, the main components of the remuneration of the Executive Directors are as follows:

  • a fixed annual component set by the Board of Directors on the basis of the comprehensive fee approved by the Shareholders' Meeting for the generality of Directors. Executive Directors may receive fees from Group companies for activities performed at those companies, in annual amounts not exceeding overall the annual fixed component received by the Company;
  • an annual variable component dependent upon the achievement of pre-set corporate targets (as per the so-called Management by Objectives method, MBO);
  • a medium to long-term variable component (in the form of both a monetary incentive and corporate financial instrument-based incentive plans);
  • non-monetary benefits.

Specifically, on the basis of the remuneration allocated to individual Executive Directors, the variable component (including the annualized medium- to long-term component), in its maximum amount, accounts for between 62% and 79% of the total annual monetary remuneration.

Chairperson of the Board of Directors

The main components of the remuneration of the Chairperson of the Board of Directors are as follows:

  • a fixed annual component set by the Board of Directors on the basis of the comprehensive fee approved by the Shareholders' Meeting for the generality of Directors;
  • a fixed annual component set by the Board of Directors for participation in its committees;

Non-Executive Directors

The main components of the remuneration of Non-Executive Directors are as follows:

  • a fixed annual component set by the Board of Directors on the basis of the comprehensive fee approved by the Shareholders' Meeting for the generality of Directors;
  • a fixed annual component set by the Board of Directors for participation in its committees.

Statutory Auditors

As per law and the By-Laws, the remuneration of Supervisory Board members is set by the Shareholders' Meeting on appointment for the entire duration of office. There are no variable remuneration components.

Senior Executives

The main components of the remuneration of Senior Executives are as follows:

  • a fixed annual component (GAR); Senior Executives may receive fees from Group companies for activities performed at those companies;
  • a variable component, in the form of both a monetary incentive and corporate financial instrument-based incentive plans;
  • retention bonuses of a monetary nature;
  • an annual sum as severance pay;
  • non-monetary benefits.

In particular, we note that, on the basis of the remuneration allocated to individual Senior Executives, the variable component, in its maximum amount, accounts for between 15% and 48% of the total annual monetary remuneration.

1.7 Non-monetary benefits

All Directors and Statutory Auditors are recipients of a liability policy (D&O insurance).

Executive Directors, on a case by case basis, as determined by the Board of Directors of, may be assigned: (i) a company car for mixed use; (ii) an insurance policy with a leading insurance company covering life, death, permanent disability and injuries, including due to illness, with a survivor's benefit in favor of the Director's family; (iii) a reimbursement health insurance policy, including a complete annual check-up and dental and specialist expenses, with a leading healthcare company, with coverage of no less than 70% of the expenses for the Director and the Director's family members; (iv) reimbursement of school expenses up to a maximum of Euro 75,000 per year; (v) housing expenses for residential use in Milan, where the Company is based, up to a maximum of Euro 60,000 per year.

Senior Executives, on a case by case basis, as determined by the competent bodies, may be assigned: (i) a company car for mixed use; (ii) an insurance policy in accordance with national collective bargaining agreement contracts covering permanent disability and injuries, including due to illness, with a survivor's benefit in favor of the Executive's family; (iii) a reimbursement health insurance policy, including an annual check-up and dental and specialist expenses, as envisaged under the "Marketing Managers" National Collective Bargaining Agreement; (iv) base welfare as per the company plan for Euro 4,000 per year; (v) housing expenses for residential use in Milan, where the Company is based, up to a maximum

of Euro 25,000 per year.

Performance Targets providing the basis of variable remuneration 1.8 components and assessment of their achievement. Rights accrual, deferred payment systems and ex-post correction mechanisms terms.

1.8.1 Executive Directors

MBO

An annual monetary variable Management by Objectives (for the purposes of this subparagraph, "MBO") remuneration is envisaged for each Executive Director on achieving specific performance targets (for the purposes of this sub-paragraph, the "MBO Performance Targets"), as indicated below.

The maximum MBO payable to each of the Executive Directors is Euro 300,000, on achievement of all MBO Performance Targets (for the purposes of this sub-paragraph, the "Maximum Amount").

Performance Targets and assessment of their achievement

MBO Performance Targets and assessment of their achievement for the Chief Executive Officer

The MBO amount is divided into two components (Component A, and Component B), to which the Chief Executive Officer will be entitled on the basis of the achievement of the relevant MBO Performance Targets, as per the following tables.

(i) Component A

"Component A" is here given to mean an amount equal to 50% of the Maximum Amount.

The Chief Executive Officer accrues the right to the payment of Component A on the basis of the value of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, as per the following table:

Adjusted Consolidated EBITDA Component A amount to be allocated
Equal to or Greater than 100% of the 100%
Adjusted Target EBITDA
95% of the Adjusted Target EBITDA 80%
Less than 90% of the Adjusted Target 0%
EBITDA

For each financial year, the achievement of the MBO Performance Target will be verified, and the Component A amount calculated, on the basis of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, on approval of the consolidated financial statements for the year by the Board of Directors.

When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.

(ii) Component B

"Component B" is here given to mean an amount equal to 50% of the Maximum Amount.

The Chief Executive Officer accrues the right to the payment of Component B on the basis of the value of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, as per the following table:

Adjusted Consolidated EBIT Component B amount to be allocated
Equal to or greater than 100% of the 100%
Adjusted Target EBIT
95% of the Adjusted Target EBIT 80%
Less than 90% of the Adjusted Target EBIT 0%

For each year, the achievement of the MBO Performance Target will be verified, and the Component B amount calculated, on the basis of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, on approval of the consolidated financial statements for the year by the Board of Directors.

When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.

***

The Chief Executive Officer may not obtain an MBO in any amount greater than the Maximum Amount. In order to incentivize achievement of the Maximum Amount, if one component's performance target is exceeded, the excess may be allocated to the MBO, to make up for the other component not reaching 100% of its targets, up to, in any case, the limit of the Maximum Amount.

MBO Performance Targets and assessment of their achievement for Executive Directors, excluding the Chief Executive Officer

The MBO amount is divided into three components (Component A, Component B, and Component C), to which the Executive Directors (excluding the Chief Executive Officer) will be entitled on the basis of the achievement of their MBO Performance Targets, as per the proportions indicated below.

(i) Component A

"Component A" is here given to mean an amount equal, depending on the case, to 40% or to one third of the Maximum Amount.

The Executive Directors accrue the right to the payment of Component A upon achievement of specific personal Performance Targets voted on by the Board of Directors, excluding the interested party.

Specifically, for (i) the Chief Merger & Acquisition Officer, the targets relate to scouting targets and negotiating for the purpose of acquisition transactions, and (ii) for the Chief Sales Officer, the targets relate to booking contracts.

For each financial year, the achievement of the MBO Performance Target will be verified, and the Component A amount calculated, on approval, by the Board of Directors, of the consolidated financial statements for the year.

(11) Component B

"Component B" is here given to mean an amount equal, depending on the case, to 30% or to one third of the Maximum Amount.

The Executive Directors accrue the right to the payment of Component B on the basis of the value of the Adjusted Consolidated EBITDA compared to the value of the Adjusted Target EBITDA, as per the following table:

Adjusted Consolidated EBITDA Component B amount to be allocated
Equal to or Greater than 100% of the 100%
Adjusted Target EBITDA
95% of the Adjusted Target EBITDA 80%
Less than 90% of the Adjusted Target 0%
EBITDA

For each financial year, the achievement of the MBO Performance Target will be verified, and the Component B amount calculated, on the basis of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, on approval of the consolidated financial statements for the year by the Board of Directors.

When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.

((ii) Component C

"Component C" is here given to mean an amount equal, depending on the case, to 30% or to one third of the Maximum Amount.

The Executive Directors accrue the right to the payment of Component C on the basis of the value of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, as per the following table:

Adjusted Consolidated EBIT Component C amount to be allocated
Equal to or greater than 100% of the 100%
Adjusted Target EBIT
95% of the Adjusted Target EBIT 80%
Less than 90% of the Adjusted Target EBIT 0%

For each financial year, the achievement of the MBO Performance Target will be verified, and the Component C amount calculated, on the basis of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, on approval of the consolidated financial statements for the year by the Board of Directors.

When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.

* *

Beneficiaries may not obtain an MBO in any amount greater than the Maximum Amount. In order to incentivize achievement of the Maximum Amount, if one component's performance target is exceeded, the excess may be allocated to the MBO, to make up for other Components not reaching 100% of their targets, up to, in any case, the limit of the Maximum Amount.

Rights accrual, deferred payment systems and ex-post correction mechanisms terms

The MBO accrued will be paid on approval of the consolidated financial statements for the relevant financial year by the Board of Directors.

No deferred payment systems or ex-post correction mechanisms are envisaged.

2024-2026 LTI Plan

On March 12, 2024, WIT's Board of Directors, on the proposal of the Appointments and Remuneration Committee, approved a medium to long-term monetary incentive plan, for the three-year period 2024-2025, entitled the "2024-2026 Long-Term Incentive Plan" (also the "2024-2026 LTI Plan"), and reserved for the individuals identified by the Board of Directors from among WIT's Executive Directors, on the proposal of the Appointments and Remuneration Committee.

The part of the 2024-2026 LTI Plan also based on the performance of WIIT stock was approved, as per Article 114-bis of the CFA, by the Shareholders' Meeting on May 16, 2024.

The incentive provided for in the 2024-2026 LTI Plan (the "LTI Bonus") is monetary in nature, with a total maximum amount set at Euro 1,764,000 for the three-year period 2024-2025-2026. The maximum LTI Bonus payable to each beneficiary under the plan, in the event of achievement of all the set Performance Targets, is equal to 30% of the sum (the "Maximum Amount") of: (i) the gross remuneration for the office of Director, as resolved by the Board of Directors, accrued by the beneficiary between January 1, 2024 and December 31, 2026, in addition to the remuneration accrued during the same period for offices held at other Group companies. With the cost relating to the Gross Annual Salary accrued by beneficiaries that are also employees of the Company between January 1, 2024 and December 31, 2026 added to the aforementioned amount; and (ii) the annual variable monetary remuneration linked to the achievement of the short-term targets (MBOs) accrued by the beneficiary between January 1, 2024 and December 31, 2026.

The beneficiaries of the 2024-2026 LTI Plan were identified by the Board of Directors, upon the proposal of the Appointments and Remuneration Committee, in the persons of Alessandro Cozzi, Francesco Baroncelli and Enrico Rampin.

Performance Targets and assessment of their achievement

Each beneficiary is entitled to the payment of the allocated LTI Bonus provided that the specific performance targets (the "LTI Performance Targets") related to the economic and financial results of WIIT Group are achieved, as per the proportions below.

In particular, the LTI Bonus is divided into three components (Component A, Component B, and Component C), to which the beneficiaries will be entitled on the basis of the achievement of the relevant LTI Performance Targets, as per the proportions indicated below.

Component A 0

"Component A" is here given to mean an amount equal to 50% of the Maximum Amount, except as indicated below.

The beneficiary accrues the right to the payment of Component A on the basis of the socalled Volume Weighted Average Price (VWAP) of the WIIT share referring to the period between September 1, 2026 and November 30, 2026 (inclusive), as per the following table:

VWAP Component A amount to be allocated
Equal to or Greater than Euro 40 120%
Euro 38 100%
Euro 34 50%
Euro 30 20%
Less than Euro 30 0%

In the event of the revocation of the Shares from listing and trading on the EXM (the "Delisting"), the beneficiaries, from and including the year of the Delisting, will no longer be entitled to the payment of Component A. In this case, again from and including the year of the Delisting, both Components B and C will be proportionally increased in terms of the percentage of the Residual Amount (as defined below).

(ii) Component B

"Component B" is here given to mean an amount equal to 25% of the Maximum Amount, except as indicated below.

The beneficiaries accrue the right to the payment B on the basis of the value of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, as per the following table:

Adjusted Consolidated EBITDA Component B amount to be allocated
Equal to or greater than 110% of the 130%
Adjusted Target EBITDA
100% of the Adjusted Target EBITDA 100%
95% of the Adjusted Target EBITDA 35%
Less than 90% of the Adjusted Target 0%
FBITDA

The achievement of the Performance Target will be verified, and the Component B amount calculated, on the basis of the average of the percentage ratio of the Adjusted Consolidated EBITDA to the Adjusted Target EBITDA, for each of the reference years (2024-2025-2026), it being understood that the right of the beneficiaries to receive Component B is in any case dependent on the value of the Adjusted Consolidated EBITDA relating to the last year considered (i.e. the Adjusted Consolidated EBITDA for the year ending December 31, 2026) being equal to at least 95% of the Adjusted Target EBITDA.

(iii) Component C

"Component C" is here given to mean an amount equal to 25% of the Maximum Amount, except as indicated below.

The beneficiaries accrue the right to payment of Component C on the basis of the value of the Adjusted Consolidated EBIT compared to the value of the Adjusted Target EBIT, as per the following table:

Adjusted Consolidated EBIT Component C amount to be allocated
Equal to or greater than 110% of the 130%
Adjusted Target EBIT
100% of the Adjusted Target EBIT 100%
95% of the Adjusted Target EBIT 35%
Less than 90% of the Adjusted Target EBIT 1 0%

The achievement of the Performance Target will be verified, and the Component C amount calculated, on the basis of the average of the percentage ratio of the Adjusted Consolidated EBIT to the Adjusted Target EBIT, for each of the reference years (2024-2025-2026), it being understood that the right of the beneficiaries to receive Component C is in any case dependent on the value of the Adjusted Consolidated EBIT relating to the last year considered (i.e. the Adjusted Consolidated EBT for the year ending December 31, 2026) being equal to at least 95% of the Adjusted Target EBIT.

When intermediate values are achieved with respect to those indicated, the LTI Bonus amount will be determined by applying the linear interpolation method.

Beneficiaries may not obtain an LTI Bonus in any amount greater than the Maximum Amount. In order to incentivize achievement of the Maximum Amount, if one Component's performance target is exceeded, the excess may be allocated to the LTI Bonus, to make up for other Components not reaching 100% of their targets, up to, in any case, the limit of the Maximum Amount.

We note that in the event of Delisting, the beneficiaries will be entitled to the payment of Component A of the LTI Bonus as indicated below. Specifically, the beneficiaries will obtain the right to payment of Component A: (a) in the event of Delisting, following completion of a public tender offer purchase or exchange of the Shares, on the basis of the offer price (the "Offer Price"); or (b) in the event of Delisting other than as indicated in (a) above, on the basis

of the Volume Weighted Average Price (VWAP) of the WIIT share in the 60 days (inclusive) prior to the Delisting, as indicated below:

Offer Price/VWAP Component A amount to be allocated
Equal to or Greater than Euro 40 120%
Euro 38 100%
Euro 34 50%
Euro 30 20%
Less than Euro 30 0%

The amount of Component A to be attributed, as calculated above, will be reduced by applying a pro rata temporis criterion taking into account exclusively the period prior to the Delisting.

Any positive difference (the "Residual Amount") between x, the maximum amount of Component A that can be attributed, and y, the attributed Component A, will be proportionally divided in percentage terms between Component B and Component C in equal parts, up to the limit of the Maximum Amount.

Rights accrual, deferred payment systems and ex-post correction mechanisms terms

Any LTI Bonus accrued will be paid to the beneficiaries by June 30, 2027, following approval of the consolidated financial statements by the WIIT Board of Directors for the year ending December 31, 2026.

In the event that within 3 years from the date of payment of the LTI Bonus, there is evidence that such an LTI Bonus has been paid on the basis of incorrect or false data, resulting from illicit or grossly negligent conduct by one or more beneficiaries, the Board of Directors will have the right to demand from the beneficiaries, and the beneficiaries will have the obligation, to return the full amount of the LTI Bonus to the Company, without prejudice to any other rights, actions or remedies available to the Company. Such a return obligation shall remain effective even in the event of termination of the beneficiary's relationship with the Company.

2021-2026 Stock Option Plan

On March 19, 2021, WIT's Board of Directors, on the proposal of the Appointments and Remuneration Committee, approved an incentive plan entitled the "2021-2026 Stock Option Plan" (the "2021-2026 Stock Option Plan") reserved to individuals to be identified by the Board, under advisory from the Appointments and Remuneration Committee, from among the Executive Directors and Senior Executives of WIT and of the other companies of WIIT Group. The 2021-2026 Stock Option Plan was approved, as per Article 114-bis of the CFA, by the Shareholders' Meeting on May 5, 2021().

This plan provides for the grant to the beneficiaries of stock options (for the purposes of this

(1) We note that on May 13, 2021, with the approval of the Shareholders' Meeting of May 5, 2021, the Board of Directors resolved to amend the 2021-2026 Stock Option Plan to account for the implementation of the 1:10 split in WIT Shares, while keeping the substantial and economic contents of the plan unchanged.

sub-paragraph, the "Options"), which give the beneficiaries the right to receive Shares in the Company's portfolio through the exercising of the Options, in the ratio of 1 Share for each Option exercised. Specifically, the 2021-2026 Stock Option Plan provides for the grant of a maximum of 1,000,000 Options, valid for the allocation of a maximum of 1,000,000 Treasury Shares of the Company.

Performance Targets and assessment of their achievement

The granting and exercise of Options are not contingent on achieving performance targets.

Rights accrual, deferred payment systems and ex-post correction mechanisms terms

Exercise of the Options

Options may be exercised by beneficiaries in whole or in part:

  • for a maximum number equal to 50% of the total Options granted to each beneficiary, commencing, alternatively, as indicated by the Company in the related plan participation letter sent to each beneficiary, (i) on January 1, 2024 or (ii) on July 1, 2024 (the "First Date"); and
  • for 100% of the total Options granted to each beneficiary, commencing, alternatively, as indicated by the Company in the related plan participation letter sent to each beneficiary, (i) on January 1, 2026 or (ii) on July 1, 2026.

Loss of the Option Exercising Right and the Early Option Exercising Right

Beneficiaries permanently lose the right to exercise the Options if within 12 months from the date of approval of the 2021-2026 Stock Option Plan by the Shareholders' Meeting, as per Article 114-bis of the CFA, that is, by May 5, 2022, one of the following events occurs:

  • change of control pursuant to Article 93 of the CFA, even if this does not imply the obligation to promote an Offer (as defined below);
  • commencement of the acceptance period for a public tender and/or exchange offer for . the Company's Shares pursuant to Article 102 and thereafter of the CFA (for the purposes of this sub-paragraph, the "Offer"); or
  • delisting from the EXM of the Shares.

After 12 months from the date of approval of the 2021-2026 Stock Option Plan by the Shareholders' Meeting, as per Article 114-bis of the CFA, that is, from May 5, 2022, the beneficiaries have the right to exercise the Options granted to them in advance of the dates indicated in the previous sub-paragraph "Exercise of the Options" (for the purposes of this sub-paragraph, the "Early Option Exercising Right"), if one of the following events occurs:

  • change of control pursuant to Article 93 of the CFA, even if this does not imply the obligation to promote an Offer; or
  • commencement of the period of acceptance of an Offer.

In the absence of a valid exercise of the Early Exercise Right pursuant to the terms and conditions set out for the exercise of the Options in the 2021-2026 Stock Option Plan regulation remain unchanged.

Public Offer Exercise and Delisting Exercise

Without prejudice to that indicated in the previous sub-paragraph "Loss of the Option Exercising Right and the Early Option Exercising Right", in the event of:

Offer, where the relevant bidder(s) avail themselves of the right to purchase pursuant (i) to Article 111 of the CFA (for the purposes of this sub-paragraph, the "111 Purchase Right"), the beneficiaries may exercise the Options within and no later than 3 business days from the dissemination, pursuant to Articles 36 and 50-quinquies, paragraph 2, of the Issuers' Regulation, of the notice containing the information necessary for the exercise of the 111 Purchase Right by the bidder(s) (for the purposes of this subparagraph the "Public Offer Exercise").

In the absence of a valid Public Offer Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options; or

(ii) resolution of a transaction resulting in the Delisting of the Shares from trading on the EXM (for the purposes of this sub-paragraph, the "Resolution"), the beneficiaries will be able to exercise the Options no later than 3 working days from the Resolution (for the purposes of this sub-paragraph, the "Delisting Exercise").

In the absence of a valid Delisting Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options.

****

No ex-post correction mechanisms are envisaged.

2022-2027 Stock Option Plan

On March 17, 2022, WIIT's Board of Directors, on the proposal of the Appointments and Remuneration Committee, approved an incentive plan entitled the "2022-2027 Stock Option Plan" (the "2022-2027 Stock Option Plan"), reserved to the Chairperson of the Board, in addition to Executive Directors, Senior Executives and Key Managers of the Group companies identified by the Board, under advisory from the Appointments and Remuneration Committee. The 2022-2027 Stock Option Plan was approved, as per Article 114bis of the CFA, by the Shareholders' Meeting on April 21, 2022.

This plan provides for the grant to the beneficiaries of stock options (for the purposes of this sub-paragraph, the "Options"), which give the beneficiaries the right to receive Shares in the Company's portfolio through the exercising of the Options, in the ratio of I Share for each Option exercised. Specifically, the 2022-2027 Stock Option Plan provides for the grant of a maximum of 250,000 Options, valid for the allocation of a maximum of 250,000 Treasury Shares of the Company.

Performance Targets and assessment of their achievement

The granting and exercise of Options are not contingent on achieving performance targets.

Rights accrual, deferred payment systems and ex-post correction mechanisms terms

Exercise of the Options

Options may be exercised by beneficiaries in whole or in part from July 1, 2027.

Early Option Exercising Right

After 12 months from the date of approval of the 2022-2027 Stock Option Plan by the Shareholders' Meeting, as per Article 114-bis of the beneficiaries have the right to exercise the Options granted to them in advance of the dates indicated in the previous subparagraph "Exercise of the Options" (for the purposes of this sub-paragraph, the "Early Option Exercising Right"), if one of the following events occurs:

  • change of control pursuant to Article 93 of the CFA, even if this does not imply the obligation to promote an Offer; or
  • commencement of the period of acceptance of an Offer.

In the absence of a valid exercise of the Early Exercise Right pursuant to the above, the terms and conditions set out for the exercise of the Options in the 2022-2027 Stock Option Plan regulation remain unchanged.

Public Offer Exercise and Delisting Exercise

In the event of:

(iii) Offer, where the relevant bidder(s) avail themselves of the right to purchase pursuant to Article 111 of the CFA (for the purposes of this sub-paragraph, the "111 Purchase Right"), the beneficiaries may exercise the Options within and no later than 3 business days from the dissemination, pursuant to Articles 36 and 50-quinquies, paragraph 2, of the Issuers' Regulation, of the notice containing the information necessary for the exercise of the 111 Purchase Right by the bidder(s) (for the purposes of this subparagraph the "Public Offer Exercise").

In the absence of a valid Public Offer Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options; or

(iv) resolution of a transaction resulting in the Delisting of the Shares from trading on the EXM (for the purposes of this sub-paragraph, the "Resolution"), the beneficiaries will be able to exercise the Options no later than 3 working days from the Resolution (for the purposes of this sub-paragraph, the "Delisting Exercise").

In the absence of a valid Delisting Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options.

No ex-post correction mechanisms are envisaged.

Senior Executives 1.8.2

Annual variable remuneration

An annual monetary variable Management by Objectives (for the purposes of this subparagraph, "MBO") remuneration is envisaged for each Senior Executive on achieving specific performance targets (for the purposes of this sub-paragraph, the "MBO Performance Targets"), as indicated below.

The maximum MBO payable to each of the Senior Executives is between Euro 20,000 and Euro 100,000, on achievement of all MBO Performance Targets (for the purposes of this subparagraph, the "Maximum Amount").

Performance Targets and assessment of their achievement

The MBO amount is divided into three components (Component A, Component B and Component C), to which the Senior Executive will be entitled on the basis of the achievement of the relevant MBO Performance Targets, as set out below.

Component A (1)

"Component A" refers to an amount between 22% and 35% of the Maximum Amount, as appropriate.

The Senior Executives accrue the right to the payment of Component A upon achievement of one or more specific personal Performance Targets established by the Chief Executive Officer. Specifically, depending on the functions performed, the targets relate to (i) cost savings (opex), (ii) financial and non-financial reporting, and (iii) investment management (capex).

For each financial year, the achievement of the MBO Performance Target will be verified, and the Component A amount calculated, on approval, by the Board of Directors, of the consolidated financial statements for the year.

(11) Component B

"Component B" refers to an amount between 40% and 70% of the Maximum Amount, as appropriate.

The Senior Executives accrue the right to the payment of up to 50% of Component B on the basis of the value of the Adjusted Consolidated EBITDA compared to the value of the Adjusted Target EBITDA, as per the following table:

Adjusted Consolidated EBITDA Component B amount to be allocated
Equal to or Greater than 100% of the 50%
Adjusted Target EBITDA
Less than 95% of the Adjusted Target 0%
EBITDA

The Senior Executives accrue the right to the payment of up to 50% of Component B on the basis of the value of the Adjusted Consolidated EBIT compared to the value of the Adjusted Target EBIT, as per the following table:

Adjusted Consolidated EBIT Component B amount to be allocated
Equal to or greater than 100% of the 50%
Adjusted Target EBIT
Less than 95% of the Adjusted Target EBIT 0%

For each year, the achievement of the MBO Performance Target will be verified, and the Component B amount calculated, on the basis of the value, respectively, of the adjusted consolidated EBITDA compared to the Adjusted Target EBITDA and the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, on approval of the consolidated financial statements for the year by the Board of Directors.

When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.

(iii) Component C

"Component C" refers to an amount equal to 5% of the Maximum Amount.

The Senior Executives accrue the right to the payment of Component A upon achievement of one or more specific ESG Targets.

For each financial year, the achievement of the MBO Performance Target will be verified, and the Component C amount calculated, on approval, by the Board of Directors, of the consolidated financial statements for the year.

Beneficiaries may not obtain an MBO in any amount greater than the Maximum Amount.

* * *

No deferred payment systems or ex-post correction mechanisms are envisaged.

2021-2026 Stock Option Plan

See Section I, Paragraph 1.8.1, Sub-Paragraph "2021-2026 Stock Option Plan", of this Report.

2022-2027 Stock Option Plan

See Section I, Paragraph 1.8.1, Sub-Paragraph "2022-2027 Stock Option Plan", of this Report.

Retention bonus

A retention bonus of up to Euro 30,000 gross annually may be provided for Senior Executives.

Considering the nature of the bonus, which is designed to incentivize the retention of beneficiaries in the Company until December 31, 2027, if the beneficiary's employment relationship should end before that date due to resignation or any other reason beyond WIIT's

control, the beneficiary will be required to return the retention bonus portions (including by offsetting severance pay).

1.9 Contribution of the Remuneration Policy to the pursuit of the Company's business strategy and long-term interests with particular reference to the variable components

The pursuit of the Company's business strategy and long-term interests is ensured by the variable remuneration components set out in the Remuneration Policy and, specifically, the 2024-2026 LTI Plan, the 2021-2026 Stock Option Plan, the 2022-2027 Stock Option Plan.

Specifically, the 2024-2026 LTI Plan, which covers the three-year period 2024-2026, provides that remuneration may be paid only at the end of the plan period (i.e. after approval of the consolidated financial statements for the financial year ended December 31, 2026) on the basis of: (i) partly the achievement of economic and financial targets for the financial years 2024-2025-2026; and (ii) partly the achievement of certain values of the WIIT stock at the end of the plan period, thus orienting the beneficiaries towards strategies for the pursuit of medium-long term results.

We also note that with respect to the 2021-2026 Stock Option Plan and the 2022-2027 Stock Option Plan, (i) the payment of any remuneration in the form of Shares is intended to also link the beneficiaries' remuneration to the actual performance of WIIT stock, thus aligning the interests of the latter with those of the shareholders; and (ii) the exercise price of the Options has been set at a value higher than the market value of the Shares on approval of the plan in order to incentivize beneficiaries towards the creation of value in WIT stock in the period following the grant date of the Options.

1.10 Information on clauses for the maintenance in portfolio of financial instruments after their acquisition

The Company's equity-based compensation plans do not include provisions for retaining equity instruments after their acquisition.

1.11 Treatments established in the event of termination of office or employment

As regards Directors who are both employees and Senior Executives, the economic treatment paid on termination of employment is regulated in accordance with and within the limits of the provisions of the national collective bargaining agreements, from time in force, applicable to the existing employee relationship, except as described below.

**

The following terms and conditions will govern the relationship between WIIT and the 2024-2026 LTI Plan MBO beneficiaries in the event of termination.

Revocation of mandate or resignation

In the event that the relationship ends prior to the expiry of the performance period as a result of termination by WIT or termination by the beneficiary, unless otherwise determined by the Board of Directors, the beneficiary shall not be entitled to receive any monetary award. In such a scenario, no compensation and/or indemnity shall be payable by WIT for any damages and/or prejudice suffered by the beneficiaries.

In the event that the relationship ends after the expiry of the performance period but before the actual payment of the monetary award, the beneficiary will still be entitled to receive any monetary award accrued.

Disability

Should the relationship end due to supervening permanent disability, the Beneficiary shall retain the rights attributed, but the amount of the monetary award shall be redetermined pro rata, taking into account - and consequently reducing the amount of the monetary award - the date on which the relationship ceased.

in such an event, the monetary award, redetermined according to the pro rata criterion identified above, shall in any case be paid at the end of the performance period.

Death of the beneficiary

Subject to the limits and conditions established for the incentive system, the beneficiary's heirs shall be entitled to receive the monetary award redetermined by applying a pro rata criterion that will take into account - and therefore reduce the amount of the monetary award accordingly - the date on which the beneficiary's death occurred.

In such an event, the monetary award, redetermined according to the pro rata criterion identified above, shall in any case be paid at the end of the performance period.

Other causes of termination

Where the beneficiary's term of office as Director ends during the performance period for reasons other than those indicated in the preceding paragraphs, the beneficiary shall retain the rights granted in accordance with the following provisions and specifically:

  • in the event that, following the termination, WIT's Shareholders' Meeting should reappoint the beneficiary to a new term as Director (with the granting of proxies and management powers), the relationship as Director shall be deemed to continue for the duration of the performance period without interruption and - subject to the limits and conditions established by the incentive system - the beneficiary shall be entitled to the monetary award in its full amount; and
  • in the event that, following termination, WIIT's Shareholders' Meeting does not grant the beneficiary a new term of office as Director - in compliance with the limits and conditions established by the incentive system - the beneficiary shall be entitled to the monetary award, but the amount shall be reduced and redetermined by applying a "pro rata" criterion taking into account the period during which s/he actually served as Director.

Should the Beneficiary's employment relationship cease during the performance period for reasons other than those indicated above, the Beneficiary shall retain the rights granted in accordance with the provisions below and, specifically - subject to the limits and conditions established by the incentive system - the Beneficiary shall be entitled to the monetary award, but the amount shall be reduced and redetermined by applying a "pro rata" criterion taking

*

into account - and therefore reducing the amount of the monetary award accordingly - the date on which the termination of employment occurred.

**

As regards rights granted under incentive plans based on financial instruments, we note that for the 2021-2026 Stock Option Plan and the 2022-2027 Stock Option Plan, the beneficiaries will lose the right to exercise the options already granted in the event of:

  • termination of the office or employment relationship by virtue of which they were indicated as Beneficiaries of the Plan occurring (i) due to revocation or dismissal for just cause; (ii) due to resignation without just cause; or (iii) following the attainment of the conditions for retirement;
  • unpaid leave of absence.

Except for the cases indicated above, the beneficiaries shall retain their right to exercise the options under the terms and conditions set out in the plan regulations regardless of the events relating to their office or role by virtue of which they were designated as beneficiaries under the plans.

* *

As regards the MBO for Senior Executives, the bonus shall be paid provided that the beneficiary is an employee of the Company at the time of disbursement. Specifically, the bonus shall not be paid in the case of dismissal for just cause pursuant to Article 2119 of the Civil Code or in the case of resignation for reasons other than just cause.

Notwithstanding the foregoing, the award shall be recognized where the employment relationship is terminated due to causes beyond the control of the beneficiary as follows:

  • । dismissal with objective justification pursuant to Article 2118 of the Civil Code;
  • resignation for just cause determined in court of law;
  • dismissal or resignation due to serious illness that make performance impossible, or resignation due to the need to provide continuous care for a spouse or family member within the third degree of kinship suffering from a disabling illness or in the event of death (in which case the bonus will be recognized to the Beneficiary's heirs).

1.12 Insurance, social security or pension coverage, other than mandatory benefits

No social security or pension coverage other than mandatory coverage is provided. For information on insurance coverage other than compulsory insurance, see Section I, paragraph 1.7.

1.13 Remuneration policy in relation to Independent Directors, Committee attendance and the discharge of particular appointments

For the entire term of office of the Board of Directors, the following is provided for: (i) a gross annual remuneration to be attributed to the members of the Appointments and Remuneration Committee, in the amount of Euro 12,000 for the Chairperson and Euro 9,000 for each other member, in addition to the reimbursement of expenses incurred in the

performance of their respective functions; (ii) a gross annual remuneration to be attributed to the members of the Control, Risks and Related Parties Committee, in the amount of Euro 12,000 for the Chairperson and Euro 9,000 for each other member, in addition to the reimbursement of expenses incurred in the performance of their respective functions.

There is no specific compensation policy for Independent Directors.

Finally, the Board of Directors allocated the total annual gross remuneration awarded by the Shareholders' Meeting of May 16, 2024 as follows:

  • to Enrico Giacomelli, Chairperson of the Board of Directors, a gross annual amount of Euro 40,000;
  • to Alessandro Cozzi, Chief Executive Officer, a gross annual amount of Euro 335,000({}; .
  • to Francesco Baroncelli, Chief Merger & Acquisition Officer, a gross annual amount of -Euro 260,000;
  • to Enrico Rampin, Chief Sales Officer, a gross annual amount of Euro 200,000; -
  • to each of the Non-Executive Directors other than the Chairperson, a gross annual . amount of Euro 15,000.

1.14 Reference remuneration policies

Although the Remuneration Policy was not defined using other companies as a reference, we note that overall, it is in line with the policies of other companies.

1.15 Exceptions to the Remuneration Policy in the presence of exceptional circumstances, and subject to the provisions of Regulation No. 17221 of March 12, 2010, any further procedural conditions under which departures may be applied.

Pursuant to Article 123-ter, paragraph 3-bis, of the CFA, the Company may make exceptions to the Remuneration Policy in the event of exceptional circumstances. Such situations are understood to mean those in which a departure from the Remuneration Policy is necessary in order to pursue the long-term interests and sustainability of the Company as a whole or to ensure its ability to compete on the market. Specifically, "Exceptional Circumstances" include, but are not limited to:

  • the occurrence, at national or international level, of extraordinary and unforeseeable events concerning the Group and/or the sectors and/or markets in which it operates, which significantly affect the Group's results, including the occurrence of significant negative effects not only of an economic or financial nature;
  • the intervention of substantial changes in the organization of the business activity, both of an objective nature (such as corporate transactions, mergers, disposals, etc.), and of a subjective nature, such as significant changes in the composition of the Board of Directors or the Senior Executives;

(4) Alessandro Cozzi, Chief Executive Officer, is also the recipient of fixed remuneration from Group companies totaling Euro 335,000.

significant changes in the perimeter of the Company's activity during the period of . validity of the Remuneration Policy, such as the sale of a company/business unit on whose activity the performance targets of the Remuneration Policy were based, or the acquisition of a significant business not contemplated for the purposes of the preparation of the Remuneration Policy.

Such exceptions may be applied to the fixed and variable components of the remuneration of the beneficiaries of the Remuneration Policy, and include, by way of example, the vesting amounts and terms of such components and the performance targets linked to the variable components.

Any temporary exceptions to the Remuneration Policy must be approved by the Board of Directors, after consultation with the Company's Appointments and Remuneration Committee and Control, Risks and Related Parties Committee.

SECTION II

This Section II - prepared as per Article 123-ter, Paragraph 4, of the CFA - will be submitted for a non-binding vote of the Shareholders' Meeting called for April 29, 2025, as per Article 123ter, Paragraph 6, of the CFA. Specifically, this section - the preparation of which was subject to verification by the party appointed to carry out the legal audit (i.e., Deloitte & Touche S.p.A.) -illustrates the remuneration for the year 2024 paid to the members of the Board of Directors (i.e., the Executive and Non-Executive Directors), the members of the Board of Statutory Auditors and the Senior Executives, providing in particular the information required by Annex 3A, Schedule 7-bis, of the Issuers' Regulation. We note that no General Managers have been appointed.

No Senior Executive received higher total remuneration than the highest total remuneration awarded to members of the Board of Directors for 2024.

We note that the Board of Directors and the Board of Statutory Auditors were renewed in FY 2024 following the expiration of the terms of office of the previous corporate boards.

PART ONE

This section sets out each of the items that comprise remuneration for 2024, including any benefits provided in the event of termination of employment or termination of employment.

1.1 Remuneration

With regard to the indication of the proportion between fixed and variable remuneration, reference should be made to Table 1 at the end of this Remuneration Report.

1.1.1.1 Remuneration of Non-Executive (including independent) Directors

Fixed Remuneration

As regards the members of the Board of Directors appointed on May 16, 2024 (all of whom were in office as of the close of FY 2024), the Company awarded the Non-Executive Directors, in addition to the reimbursement of out-of-pocket and documented expenses, the following remuneration:

  • to Enrico Giacomelli, (Chairperson of the Board of Directors) a gross annual amount of Euro 25,000;
  • to Annamaria Di Ruscio (Independent Director) a gross amount of Euro 15,000;
  • to Emanuela Teresa Basso Petrino (Independent Director) a gross amount of Euro 15,000;
  • to Nathalie Brazzelli (Independent Director) a gross amount of Euro 15,000;
  • to Chiara Grossi (Non-Independent Director) a gross amount of Euro 15,000. In addition, Chiara Grossi was paid a gross annual remuneration as an Executive of WIT amounting to Euro 138,440;
  • to Santino Saguto (Independent Director) a gross amount of Euro 9,375.

As regards the members of the Board of Directors whose term expired in FY 2024, the

Company awarded the Non-Executive Directors the following remuneration, in addition to reimbursement of out-of-pocket expenses:

  • to Riccardo Sciutto (Chairperson of the Board of Directors) a gross amount of Euro 14,500(3);
  • to Stefano Pasotto (Non-Independent Director) a gross amount of Euro 5,625. In addition, Stefano Pasotto was paid a gross annual remuneration as an Executive of WIIT amounting to Euro 110,000.

Remuneration for committee participation

As regards the members of the Board of Directors appointed on May 16, 2024 (all of whom were in office as of the close of FY 2024), the Company awarded the Committee members, in addition to the reimbursement of expenses incurred in the exercise of their duties, the following remuneration:

  • to Enrico Giacomelli (member of the Appointments and Remuneration Committee and the Control, Risks and Related Parties Committee) a gross amount of Euro 11,250;
  • to Annamaria Di Ruscio (member of the Appointments and Remuneration Committee and Chairperson of the Control, Risks and Related Parties Committee) a gross amount of Euro 21,000;
  • to Emanuela Teresa Basso Petrino (Chairperson of the Appointments and Remuneration Committee) a gross amount of Euro 12,000;
  • to Nathalie Brazzelli (member of the Control, Risks and Related Parties Committee), a gross amount of Euro 9,000.

As regards the members of the Board of Directors whose term expired in FY 2024, the Company granted the following remuneration to committee participants, in addition to reimbursement of expenses incurred in the performance of their respective duties:

  • to Riccardo Sciutto (previously member of the Appointments and Remuneration Committee and the Control, Risks and Related Parties Committee) a gross amount of Euro 7,250;

1.1.2 Executive Directors' remuneration

Fixed Remuneration

The Company awarded the Non-Executive Directors the following fixed remuneration, in addition to reimbursement of out-of-pocket expenses:

  • to Alessandro Cozzi, Chief Executive Officer, a gross annual amount of Euro 642,708, of which Euro 321,875 from the Company, Euro 300,000 from WIIT AG and Euro 20,833 from Econis AG;
  • to Francesco Baroncelli, Chief Mergers & Acquisition Officer, a gross annual amount of

(*) He also received as non-monetary remuneration the use of a car (fringe benefit totaling Euro 7,047).

Euro 260,000;

to Enrico Rampin, Chief Sales Officer, a gross annual amount of Euro 220,833, of which Euro 200,000 from the Company and Euro 20,833 from Econis AG;

Variable Remuneration

In line with Section I of the 2024 Remuneration Report, the Company paid the following variable remuneration to Executive Directors in 2024:

  • to Alessandro Cozzi, Chief Executive Officer, a total amount of Euro 294,096, due to the achievement of an Adjusted Consolidated EBITDA equal to 103.2% of the Adjusted EBITDA Target (Component A) and an Adjusted Consolidated EBIT equal to 96.6% of the Adjusted EBITDA Target (Component B), as set out in Section I, Section 1.8.1, Sub-Paragraph "MBO Performance Targets and assessment of their achievement for the Chief Executive Officer" of the 2024 Remuneration Report;
  • to Francesco Baroncelli, Chief Mergers & Acquisition Officer, a total amount of Euro 296,064, due to the achievement of a Adjusted Consolidated EBITDA equal to 103.2% of the Adjusted EBITDA Target (Component A) and an Adjusted Consolidated EBIT equal to 96.66% of the Adjusted EBITDA Target (Component B), and 100% of the Component C targets (relating to scouting targets and negotiating for the purpose of acquisition transactions), as set out in Section 1.8.1, Sub-Paragraph "MBO Performance Targets and assessment of their achievement for the Executive Directors except the Chief Executive Officer" of the 2024 Remuneration Report;
  • to Enrico Rampin, Chief Sales Officer, a total amount of Euro 296,064, due to the achievement of a Adjusted Consolidated EBITDA equal to 103.2% of the Adjusted EBITDA Target (Component A) and an Adjusted Consolidated EBIT equal to 96.6% of the Adjusted EBITDA Target (Component B), and 100% of the Component C targets (relating to the total value of the annual fees of all contracts signed with Group customers (Italy and Germany) and the total value of the annual fees of all contracts signed with WIIT S.p.A.), as set out in Section 1.8.1, Sub-Paragraph "MBO Performance Targets and assessment of their achievement for the Executive Directors except the Chief Executive Officer" of the 2024 Remuneration Report.

Finally, with reference to the 2024-2026 LTI Plan, we note that, in line with the rules set out by the Company's Remuneration Policy on long-term incentives, no compensation was paid to the beneficiaries as it is envisaged that any payment of such compensation will be deferred until after the approval of the 2026 consolidated financial statements.

The pay mix of Executive Directors was therefore as follows:

  • Alessandro Cozzi: 68.60% fixed remuneration and 31.40% variable remuneration;
  • Francesco Baroncelli: 46.75% fixed remuneration and 53.25% variable remuneration;
  • Enrico Rampin: 42.72% fixed remuneration and 57.28% variable remuneration.

Non-monetary compensation

The following non-monetary compensation was provided:

  • (i) to Alessandro Cozzi:
    • a Band A car (fringe benefit totaling Euro 2,250; car provided by WIIT AG);
    • an insurance policy with a leading company to cover life, death, permanent invalidity and injury, including due to illness, with the right of survivorship in favor of his family members (total cost to the Company of Euro 2,524);
    • a reimbursable health insurance policy with a leading health care company, including a full annual check-up (or coverage of the expenses of the annual checkup if not included in the insurance) and dental and specialist expenses, with coverage of no less than 70% of the expenses for the Director and his family members (spouse or cohabiting partner and children) (total cost of the company equal to Euro 22,272);
    • reimbursement of school expenses for a total of Euro 61,838;
  • (i) to Enrico Rampin:
    • a Band B car (fringe benefit totaling Euro 8,887);
    • an insurance policy with a leading company to cover life, death, permanent invalidity and injuries, including due to illness, with the right of survivorship in favor of his family members (total cost to the Company of Euro 1,733);
    • a reimbursable health insurance policy with a leading health care company, including a full annual check-up (or coverage of the expenses of the annual checkup if not included in the insurance) and dental and specialist expenses, with coverage of no less than 70% of the expenses for the Director and his/her family members (spouse or cohabiting partner and children) (total cost to the company of Euro 4,997);
    • reimbursement of school expenses for a total of Euro 20,000;
    • allocation of rented accommodation (total cost to the Company of Euro 60,000);
  • to Francesco Baroncelli: (ii)
    • a Band B car (fringe benefit totaling Euro 6,959);
    • an insurance policy with a leading company to cover life, death, permanent invalidity and injuries, including due to illness, with the right of survivorship in favor of his family members (total cost to the Company of Euro 1,276);
    • a reimbursable health insurance policy with a leading health care company, including a full annual check-up (or coverage of the expenses of the annual checkup if not included in the insurance) and dental and specialist expenses, with coverage of no less than 70% of the expenses for the Director and his/her family members (spouse or cohabiting partner and children) (total cost to the company of Euro 4,997);
    • reimbursement of other expenses (other than school expenses) for a total of Euro 20,000.

1.1.3 Remuneration of members of the Board of Statutory Auditors

As regards the standing members of the Board of Statutory Auditors appointed on May 16, 2024 (all of whom were in office at the close of FY 2024), the following remuneration was paid to the standing members of the Board:

  • Euro 18,770.49, plus Euro 765.41 in statutory contributions and expenses, to Vieri Chimenti (Chairperson);
  • Euro 19,250, plus Euro 770.00 in statutory contributions and expenses, to Paolo Ripamonti (Statutory Auditor and former Chairperson until May 16, 2024);
  • Euro 17,004, plus Euro 680.16 in statutory contributions and expenses, to Chiara Olliveri Siccardi (Statutory Auditor).

As regards the standing members of the Board of Statutory Auditors leaving office in FY 2024, the following remuneration was paid to the standing members of the Board:

  • Euro 5,000, plus Euro 208.12 in statutory contributions and expenses, to Francis De Zanche (Statutory Auditor).

1.1.4 Remuneration of Senior Executives

Fixed Remuneration

Gross fixed remuneration paid to Senior Executives totaled Euro 358,447, of which Euro 248,446 attributable to Non-Executive Directors (and Senior Executives) Stefano Pasotto (who left the office of Director on May 16, 2024) and Chiara Grossi.

Variable Remuneration

Gross variable monetary remuneration paid to Senior Executives totaled Euro 164,280, of which Euro 95,191 attributable to Non-Executive Directors (and Senior Executives) Stefano Pasotto (whose term as Director ended on May 16, 2024) and Chiara Grossi.

Non-monetary compensation

The Company granted the Senior Executives the following non-monetary benefits for a total of Euro 98,190 (of which Euro 55,358 attributable to Non-Executive Directors [and Senior Executives] Stefano Pasotto [who left the office of Director on May 16, 2024] and Chiara Grossi): (i) a company car for mixed use; (ii) an insurance policy with a leading insurance company covering permanent disability and accidents, including due to illness, with a survivor's benefit in favor of the Executive's family; (iii) a reimbursement health insurance policy, including a complete annual check-up and dental and specialist expenses, as envisaged under the "Marketing Managers" National Collective Bargaining Agreement; (iv) reimbursement of school expenses; (v) housing expenses for residential use in Milan, where the Company is based.

1.2 Allocation of indemnities and/or other benefits for termination of office or termination of employment during the year

No indemnities and/or other benefits for termination of office or termination of employment were allocated.

1.3

The Company did not make exceptions to the Remuneration Policy.

1.4 Application of ex-post adjustment mechanisms for the variable component (malus or clawback of variable remuneration)

Ex-post adjustment mechanisms for the variable component (malus or clawback of variable remuneration) were not applied.

Comparison information 1.5

Comparative information is provided below for 2020, 2021, 2023 and 2024, regarding the annual changes in:

(i) Total remuneration paid by WIT to each of the persons for whom this Section I of the Remuneration Report is provided by name

Name Office Year
2024 2023 2022 2021 2020
Absolute
value
(Euro)
% change on
previous year
Absolute
value
(Euro)
% change on previous
year
Absolute
value
(Euro)
% change on previous
year
Absolute
value
(Euro)
% change on previous
year
Absolute
value
(Euro)
IN OFFICE
Enrico
Giacomelli
Chairperson of the Board of Directors 36,250 100.00%
Alessandro
Cozzi
Chief Executive Officer 781,438 8.99% 716,916 -10% 794,188 -13% 912,205 51% 602,546
Enrico Rampin Chief Sales Officer 612,084 2.85% 595,117 42% 418,822 -14% 488,321 97% 247,879
Francesco
Baroncelli
Chief Mergers & Acquisition Officer 610,320 3.46% 589,873 26% 469,225 -14% 544,791 103% 268,514
Di
Annamaria
Ruscio
Independent Director 36,000 0.00% 36,000 0% 36,000 50% 24,000 0% 24,000
Emanuela
Basso Petrino
Independent Director 27,000 0.00% 27,000 0% 27,000 50% 18,000 -
Nathalie
Brazzelli(*)
Independent Director 24,000 0.00% 24,000 0% 24,000 50% 16,000 12,000(*)
Chiara Grossi Non-Executive Director
Senior
(and
Executive)
284,828 6.68% 266,976 70% 157,410
Santino Saguto Independent Director 9375 100.00% -
Vieri Chimenti Chairperson of the Board of Statutory
Auditors
18770.49 100.00% - -
Paolo
Ripamonti
Statutory Auditor (formerly Chairperson of
the Board of Statutory Auditors until May 16,
2024)
19,250 6.94% 18,000 0% 18,000 8% 16,650 39% 12,000
Chiara Olliveri
Siccardi
Statutory Auditor 17,004 41.70% 12,000 0% 12,000 50% 8,000 -

LEFT OFFICE
Riccardo
Sciutto
Chairperson of the Board of Directors 21,750 -70.41% 27% 58,000 50% 7% 36,000
Stefano
Pasotto
Non-Executive Director
(and
Senior
Executive)
162,923 -9.84% 180,707 100% - - - -
Francis
De
Zanche
Statutory Auditor 5,000 -58.33% 12,000 0% 12,000 50% 8,000 - -

(*) In 2020, Nathalie Brazzelli received an annual fee of Euro 12,000 but in relation to her position as Statutory Auditor.

(ii) results of WIIT and the Group

WIIT

Performance
indicator
Year
2024 2023 2022 2021 2020
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
Adjusted revenues 61.6 6% 58.3 9% 53.2 85% 29 12% 25.7
Adjusted EBITDA 27.7 5% 26.3 24% 21.2 71% 12 13%
Adjusted EBIT 11.5 -90% 12.7 25% 10.2 149% 2%
Adjusted Net Profit 3.6 -62% 9.7 46% 6.6 182% 2 -64% 6.5

NE: We note that (j the meger of Adelante S.p.A., and Easte in 2022; and the menger of Entern Sp.A., into WIT was frailied in 2003, so the restlis in 1203, so the esse and to

extent comparable with the results of previous years.

Group

Performance indicator Year
2024 2023 2022 2021 2020
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
% change on
previous year
Absolute value (Euro
millions)
Consolidated adjusted
revenues
158.6 22% 130.1 10% 118.8 54% 77 47% 52.5
Adjusted consolidated
EBITDA
28 14% 50.8 20% 42.2 41% 30 63% 18.3
Adjusted Consolidated
EBIT
29 4% 28.0 21% 23.2 48% 16 74% ರಿ
Adjusted Consolidated
profit
14.7 -3% 15.1 21% 12.5 36% ರಿ 50% 6.1

(ii) average gross annual remuneration full-time employees, of WIT employees other than those whose remuneration is represented in this section II of the Remuneration Report

Performance indicator Year
2024 2023 2022 2021
Absolute value
(Euro)
% change on
previous year
Absolute value
(Euro)
% change on
previous year
Absolute value
(Euro)
% change on
previous year
Absolute value
(Euro)
% change on
previous year
Absolute value
(Euro)
Average gross annual remuneration of full-
time WIIT employees
44,657 (*) 10.27% 40,498 (*) 2.99% 39,324(*) 6.26% 37,006(*) 3.18% 35,864(*)

(*) This value does not take into account any variable remuneration paid.

1.6 Shareholders' Meeting vote on Section II of the Remuneration Report for the previous year

In accordance with the provisions of Article 123-ter, paragraph 6 of the CFA, the Shareholders' Meeting of May 16, 2024 cast a non-binding vote on Section II of the 2024 Remuneration Report. Votes in favor totaled 71.348661% of the total voting rights and 90.873382% of the total voting rights present.

SECOND PART

TABLE 1: Remuneration of the Board of Directors, Board of Statutory Auditors, and Senior Executives

(A) (B) (C) (D) 1 2 3 5 6 7 8
Period of Fixed
remuneratio
n
Remuneration
for committee
participation
Non-equity variable
remuneration
Non- Other Fair Value
of equity
Benefits on
Name Office office Concl. of office Bonuses and
other
incentives
Profit
sharing
monetary
benefits
remunerati
on
Total remunerati
on
conclusion
of office
MEMBERS OF THE BOARD OF DIRECTORS IN OFFICE
Enrico Giacomelli Chairperson 16/05/2024 -
31/12/2024
Appr. 2026
Annual
Accounts
25,000 11,250 36,250
Alessandro Cozzi Chief Executive
Officer
01/01/2024 –
31/12/2024
Appr. 2026
Annual
Accounts
(I) Remuneration from company preparing the accounts 294,096 165,467 781,438
(II) Remuneration from subsidiaries and associated companies 320,833 320,833
(III) Total 642,708 294,096 165,467 1,102,271
Enrico Rampin Chief Sales
Officer
01/01/2024 –
31/12/2024
Appr. 2026
Annual
Accounts
(I) Remuneration from company preparing the accounts 200,000 296,064 116,020 612,084
(II) Remuneration from subsidiaries and associated companies 20,833 20,833
(III) Total 296,064 116,020 632,917
Francesco Baroncelli Chief Mergers &
Acquisition
Officer
01/01/2024 -
31/12/2024
Appr. 2026
Annual
Accounts
(I) Remuneration from company preparing the accounts 260,000 296,064 54,256 610,320
(II) Remuneration from subsidiaries and associated companies 50,000(*) 50,000

(A) (B) (C) (D) 1 2 3 4 5 6 7 8
Office Period of Fixed Remuneration
for committee
participation
Non-equity variable
remuneration
Non- Other Total Fair Value
of equity
Benefits on
Name office Concl. of office remuneratio
n
Bonuses and
other
incentives
Profit
sharing
monetary
benefits
remunerati
on
remunerati
on
conclusion
of office
(III) Total 260,000 296,064 54,256 50,000 660,320
Annamaria Di Ruscio Independent
Director
01/01/2024 –
31/12/2024
Appr. 2026
Annual
Accounts
15,000 21,000 36,000
Emanuela Basso Petrino Independent
Director
01/01/2024 -
31/12/2024
Appr. 2026
Annual
Accounts
15,000 12,000 27,000
Nathalie Brazzelli Independent
Director
01/01/2024 –
31/12/2024
Appr. 2026
Annual
Accounts
15,000 9,000 24,000
Chiara Grossi Director
(and Senior
Executive)
01/01/2024 –
31/12/2024
Appr. 2026
Annual
Accounts
(I) Remuneration from company preparing the accounts 153,440(**) 79,885 39,487 12,016 284,828
(II) Remuneration from subsidiaries and associated companies 6,250 6,250
(III) Total 159,690 79,885 39,487 12,016 291,078
Santino Saguto Independent
Director
16/05/2024 -
31/12/2024
Appr. 2026
Annual
Accounts
9,375 9,375
MEMBERS OF THE BOARD OF DIRECTORS LEAVING OFFICE DURING THE YEAR
Riccardo Sciutto Chairperson 01/01/2024 –
16/05/2024
Appr. 2023
Annual
Accounts
14,500 7,250 21,750
Stefano Pasotto Director 01/01/2024 -
16/05/2024
Appr. 2023
Annual
Accounts

(A) (B) (C) (D) ו 2 3 4 5 e 7 8
Period of Fixed Remuneration Non-equity variable
remuneration
Non- Other Fair Value
of equity
Benefits on
Name Office office Concl. of office remuneratio
m
for committee
participation
Bonuses and
other
incentives
Profit
sharing
monetary
benefits
remunerati
on
Total remunerati
on
conclusion
of office
(and Senior
Executive)
(I) Remuneration from company preparing the accounts 125,006(***) 15,306 15,871 6,740 162,923
(II) Remuneration from subsidiaries and associated companies 6,250 6,250
(III) Total 131,256 15,306 15,871 6,740 169,173
MEMBERS OF THE BOARD OF STATUTORY AUDITORS
Vieri Chimenti Chairperson of the
Board of Statutory
Auditors
16/05/2024 –
31/12/2024
Appr. 2026
Annual
Accounts
18,770 18,770
Paolo Ripamonti Statutory Auditor
(formerly
Chairperson of the 01/01/2024 -
Board of Statutory 31/12/2024
Auditors until
16/5/2024)
Appr. 2026
Annual
Accounts
19,250 19,250
Chiara Olliveri Siccardi Statutory Auditor 01/01/2024 -
31/12/2024
Appr. 2026
Annual
Accounts
17,004 17,004
MEMBERS OF THE BOARD OF STATUTORY AUDITORS DURING THE YEAR
Francis De Zanche Statutory Auditor 01/01/2024 –
16/05/2024
Appr. 2023
Annual
Accounts
5,000 5,000
SENIOR EXECUTIVES EXCLUDING THOSE THAT ARE ALSO DIRECTORS (***)
Number of Senior Executives: 1 110,000 69,090 42,832 6,740 228,662
SENIOR EXECUTIVES INCLUDING THOSE THAT ARE ALSO DIRECTORS (***)

(A) (B) (C) D) 8 g o 8
Name Office Period of Concl. of office remuneratio for committee Fixed Remuneration Non-equity variable
remuneration
Non- Other
remunerati
Total Fair Value
of equity
Benefits on
conclusion
office n participation Bonuses and
other
incentives
Profit
sharing
monetary
benefits
on remunerati
on
of office
Number of Senior Executives: 3 358,447 164,280 98,190 25,496 646,413

NB: values expressed in Euro.

AD France and Book and Euro Isa.
(*) In the oapacity of Jotegration Manager of Econis AQ.
(*) In the oapacity of Jotegration and Euro 138,440 as an Executive.
(***) Of which

T ABLE 2: Stock options granted to the Board of Directors, General Managers and Senior Executives

Options held at beginning of the year Options granted in the year Options exercised in the year Options
expiring in
Options held
at the end of
Options
accruing in
the year the year the year
A B (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) = (2)+(5)-
(11)-(14)
(16)
Name Office Plan Number
of
options
Exercise
price
Possible
exercise
period
(from-to)
Number
of
options
Exercise
price
Possible
exercise
period
(from- to)
Fair value at
grant date
Grant date Market price of the
underlying shares
at the grant date
Number
of
options
Exercise
price
Market price
of the
underlying
shares at the
exercise date
Number of
options
Number of
options
Fair value
Riccardo
Sciutto(*)
Chairperson 2022-2027
Stock
Option Plan
(21.04.2022)
25,000 € 40 From
01.07.27 to
01.07.28
25,000
Options held at beginning of the year Options granted in the year Options exercised in the year Options
expiring in
the year
Options held
at the end of
the year
Options
accruing in
the year
A B (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) = (2)+(5)-
(11)-(14)
(16)
Name Office Plan Number
of
options
Exercise
price
Possible
exercise
period
(from- to)
Number
of
options
Exercise
price
Possible
exercise
period
(from - to)
Fair value at
grant date
Grant date Market price of the
underlying shares
at the grant date
Number
of
options
Exercise
price
Market price
the
of
underlying
shares at the
exercise date
Number of
options
Number
of
options
Fair value
Francesco
Baroncelli
Chief
Mergers &
Acquisition
Officer
2021-2026
Stock
Option Plan
(05.05.2021)
280,000 € 18 50% from
01.07.24 to
01.07.27
100% from
01.07.26 to
- 280,000
01.07.27
Options held at beginning of the year Options granted in the year Options exercised in the year Options
expiring in
the year
Options held
at the end of
the year
Options
accruing in
the year
A B (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) = (2)+(5)-
(11)-(14)
(16)
Name Office Plan Number
of
options
Exercise
price
Possible
exercise
period
(from- to)
Number
of
options
Exercise
price
Possible
exercise
period
(from - to)
Fair value at
grant date
Grant date Market price of the
underlying shares
at the grant date
Number
of
options
Exercise
price
Market price
the
of
underlying
shares at the
exercise date
Number of
options
Number
of
options
Fair value
3 Senior Executives 2021-2026
Stock
80,000(**) € 18 50% from
01.07.24 to
- - - 80,000(**)

Option Plan 01.07.27
(05.05.2021)
100% from
01.07.26 to
01.07.27

NB: No member of the Board of Directors and no Senior Executive received remuneration from subsidiaries or associates.

(*) Left office on May 16, 2024.

(**) Of which 30,000 are held by Chiara Grossi and 30,000 are held by Stefano Pasotto.

TABLE 3B: Monetary incentive plans for members of the Board of Directors, General Managers and Senior Executives

B (1) (2) (3) (4)
Name Office Plan Bonus for the year Prior year bonuses Other bonuses
(A) (B) (C) (A) (B) (C)
Alessandro Cozzi Chief
Executive
Officer
lssuable/Issued Deferred Period of deferment No longer issuable lssuable/Issued Still deferred
(I) Remuneration from
company preparing
the accounts
Annual MBQ 294,096
(II) Remuneration from
subsidiaries
and
associated
companies
(III) Total Annual MBO 294,096
( B (1) (2) (3) (4)
Name Office Plan Bonus for the year Prior year bonuses Other bonuses
(A) (B) (C) (A) (B) (C)
Enrico Rampin Chief Sales Officer lssuable/Issued Deferred Period of deferment No longer issuable lssuable/Issued Still deferred
(I) Remuneration from
company preparing
the accounts
Annual MBO 296,064
(II) Remuneration from
subsidiaries
and
associated
companies
(III) Total Annual MBO 296,064
A B (1) (2) (3) (4)
Name Office Plan Bonus for the year Prior year bonuses Other bonuses
(A) (B) (C) (A) (B) (C)
Francesco Baroncelli Chief Mergers &
Acquisition Officer
lssuable/Issued Deferred Period of deferment No longer issuable lssuable/Issued Still deferred

(I) Remuneration from
company preparing
the accounts
Annual MBQ 296,064
(II) Remuneration from
subsidiaries
and
associated
companies
(III) Total Annual MBQ 296,064
Senior Executives Office Plan Bonus for the year Prior year bonuses Other bonuses
(A) (B) (C) (A) (B) (C)
lssuable/Issued Deferred Period of deferment No longer issuable Issuable/Issued Still deferred
(I) Remuneration from
company preparing
the accounts
Annual MBQ 164,280(*)
(II) Remuneration from
subsidiaries
and
associated
companies

(*) Of which, Euro 79,885 attributable to Chiara Grossi and Euro 15,306 to Stefano Pasotto.

Schedule 7-ter

Table 1

SHAREHOLDINGS OF THE BOARD OF DIRECTORS AND STATUTORY AUDITORS

NAME OFFICE COMPANY NUMBER OF SHARES
HELD AT 31.12.2023
DATE OF
APPOINTMENT
NUMBER OF SHARES
PURCHASED
NUMBER OF SHARES
SOLD
NUMBER OF SHARES
HELD AT 31.12.2024 /
DATE OF
DEPARTURE
DIRECTORS & STATUTORY AUDITORS
Enrico Giacomelli Chairperson WIIT S.p.A. 6,250 6,250
Alessandro Cozzi(*) Chief Executive Officer WIIT S.p.A. 15,822,202 925,000 391,302 16,355,900
Enrico Rampin(*) Chief Sales Officer WIIT S.p.A. 545,630 545,630
Francesco Baroncelli(*) Chief Mergers & Acquisition Officer WIIT S.p.A. 425,760 425,760
Annamaria Di Ruscio Independent Director WIIT S.p.A. 1,340 1,340
Emanuela Basso Petrino Independent Director WIIT S.p.A.
Nathalie Brazzelli Independent Director WIIT S.p.A.
Chiara Grossi Director (and Senior Executive) WIT S.p.A. 27,500 27,500
Santino Saguto Independent Director WIIT S.p.A.
Vieri Chimenti Chairperson of the Board of Statutory
Auditors
WIIT S.p.A.
Paolo Ripamonti Statutory Auditor WIIT S.p.A.

Chiara Olliveri Siccardi Statutory Auditor WIIT S.p.A. I - -
DIRECTORS AND STATUTORY AUDITORS LEAVING OFFICE DURING THE YEAR
Riccardo Sciutto(*) Chairperson WIIT S.p.A. 47,540 - 47,540
Stefano Pasotto Director (and Senior Executive) WIIT S.p.A. 15,150 - - 15,150
Francis De Zanche Statutory Auditor WIIT S.p.A. 1,250 - 1,250

(*) Directly and indirectly.

Table 2

SHAREHOLDINGS OF SENIOR EXECUTIVES

NUMBER OF SENIOR
EXECUTIVES
COMPANY NUMBER OF SHARES HELD NUMBER OF SHARES
AT 31.12.2023
PURCHASED NUMBER OF SHARES SOLD NUMBER OF SHARES HELD
AT 31.12.2024
WIIT S.p.A. 15.188 183 15.371

NB: For information on the holdings of Senior Executives Stefano Pasotto and Chiara Grossi, see Table 1 above.

* * *

For the Board of Directors

The Chairperson

Enrico Giacomelli

Talk to a Data Expert

Have a question? We'll get back to you promptly.